Karolina Valente

Why selected

We recognise Karolina Valente for advancing human tissue models that give drug researchers a way to study how candidates reach tissue and interact with targets. As VoxCell BioInnovation’s co-founder and chief scientific officer, she is advancing 3D-bioprinted models containing vascular networks for preclinical research. VoxCell has also offered in-house screening and efficacy data, and in 2026 announced a research collaboration with adMare BioInnovations to evaluate a novel therapeutic programme using the platform.

Selected 6 November 2026